Dr Francesco Tamagnini
A University of Reading researcher has been honoured with a reception in his home country of San Marino.
On the 13th of August 2018, the Most Excellent Regent Captains of the Republic of San Marino received in a private audience five San Marino citizens working abroad and excelling in their own respective fields.
Dr Francesco Tamagnini, Lecturer in Pharmacology at the University of Reading School of Pharmacy, was one of the five, and had the chance to talk about his research into Alzheimer’s Disease and how his career path took him from San Marino to Reading.
Continue reading →
Brain Glue: Sticking it to Dementia
Wednesday 28 February, 7.30-8.45pm
G11, Henley Business School, Whiteknights campus
This event is free to attend.
Registration in advance is not required, but is recommended as public lectures are often full. Click here to book your place >
Nearly a million people in the UK today are living with dementia. Currently there is no treatment that will prevent, cure or slow down its progression. To overcome this scientists are now studying not only nerve cells in the brain, but the so-called glial cells – previously thought to be just the ‘glue’ that sticks other brain cells together. Evidence suggests that these cells could provide insight and even early warning about the onset of disease, years before clinical symptoms develop.
The human brain is the most complex computer we have, yet we are still discovering the basics of how it works. This lecture will outline some of the challenges in finding treatments for brain diseases, and explore the potential of glial cells in the fight against Alzheimer’s disease.
Dr Mark Dallas is a Lecturer in Cellular and Molecular Neuroscience at the School of Pharmacy, University of Reading. He is the Academic Co-Ordinator for the Alzheimer’s Research UK Oxford Network, Neuroscience Theme Lead for the Physiological Society and sits on the editorial board of Physiology News.
By Dr Mark Dallas, Lecturer in Cellular and Molecular Neuroscience, University of Reading
Our hope as dementia scientists is that these cells could unlock a new avenue of treatments that alters the course of Alzheimer’s disease
The human brain is a complex structure made up of different types of cells. You have probably heard scientists talk about nerve cells or brain cells. These are the cells that are lost in Alzheimer’s disease.
However, there are a similar number of other cell types within the brain, called glial cells. ‘Glial’ comes from the Greek word for glue, as these cells were originally believed to hold the nerve cells together. It is now clear that these cells are highly specialised and vital for brain function.
So what are these cells, and how could they help us find treatments for Alzheimer’s?
Continue reading →